Open-label, single-center, randomized and parallel-group study to examine the effects of montelukast and ciclesonide on the peripheral airway inflammation in asthma using alveolar nitric oxide.

Trial Profile

Open-label, single-center, randomized and parallel-group study to examine the effects of montelukast and ciclesonide on the peripheral airway inflammation in asthma using alveolar nitric oxide.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Ciclesonide (Primary) ; Montelukast (Primary) ; Corticosteroids
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
    • 01 Mar 2010 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 22 Dec 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top